Trump has China quaking in its boots... By Steven W.

New Post Public Reply Private Reply Replies (1) Message Board
energy_wave
93
Trump has China quaking in its boots...

By Steven W. Mosher

October 6, 2018

Quote:
With China still running a record trade surplus with the US, it seems premature — to say the least — to say that Trump has won his long-overdue trade war with China.

But it is not too early to conclude that, despite their threat of retaliatory tariffs, China’s Communist authorities know that they have lost.

The increased tariffs to date, combined with the threat of more, have already clipped the wings of China’s economic rise. Its stock market is down 21 percent year over year, industrial output is slowing and its currency is weakening.

Looking beyond the bluff and bluster emanating from Beijing, there is evidence that Party leader Xi Jinping is looking for a way to stand down.

Let’s read the Chinese tea leaves.

In early July Xi ordered state-media outlets to tone down their rhetoric. “Self-deception and boasting will not bring about true self-confidence and pride,” the official Communist Party newspaper dutifully editorialized.

This sudden modesty was a striking turnabout from five years of constant bragging — by none other than “Core Leader” Xi himself.

Almost from the moment he took power in 2012, the Chinese leader was so confident that his own country’s rise was unstoppable, and so certain that America was in terminal decline, that he openly boasted about the China-dominated world to come.

The Art of War has met The Art of the Deal. And The Art of the Deal has won.

He even drew up a series of grandiose plans — China would dominate high tech by 2025, the Asia-Pacific region by 2035 and the world by 2049.

Xi may try to blame his propaganda flacks for overdoing it, but the Chinese people know who is responsible. In backing off the braggadocio, Xi is “slapping his own face,” as the Chinese say.

The Chinese state-run media has been busily throwing up a smokescreen to cover Xi’s retreat. It has launched increasingly unhinged attacks on what it calls the “lunatic,” “insane” and “terroristic” Trump administration.

After all, the masses must be told who to blame for China’s recent economic difficulties.

The official Global Times has even published an article calling for US administration officials to invoke the 25th Amendment and remove Trump from office.

In private, however, senior Chinese officials have come to view Trump as a Sun Tzu-like strategic genius.

Yes, you heard me right.

After the election, Xi Jinping tried to rope Europe and other Asian countries into a new, anti-US coalition, only to see this initiative fail.

The EU recoiled from Xi’s embrace and is now in serious free and fair trade talks with Washington.

Even the Philippines, which Xi tried desperately to woo with the promise of billions in investments, has now backed away from China.

But as Xi was stumbling, Trump went on the offensive. He signed a new trade agreement with South Korea and expanded defense cooperation with Japan and Australia.

Using the threat of tariffs as leverage, he even got Xi to agree to UN sanctions against North Korea, stifling the economy of China’s only formal ally.

This week, with the successful renegotiation of a trade agreement with Mexico and Canada — the USMCA — Trump is now able to control China’s access to the entire North American market.

Beijing officials now realize, even if many in the US foreign policy establishment don’t, that they are facing a master tactician, one who is moving steadily from deal to deal, getting as many concessions as he can, and then moving on the next.

But they also see Trump as not just transactional, but strategic. He is pressuring China not just on the economic front, but on the military and ideological front as well. They fear that his goal is not just to rectify the trade deficit, but to eliminate the threat that a rising China poses to the US.

The Chinese have been set on their heels by an American adversary who quotes Sun Tzu: “The supreme art of war is to subdue the enemy without fighting.”

The Art of War has met The Art of the Deal. And The Art of the Deal has won.

Only the terms of the surrender remain to be negotiated.

China is eager to resume talks but, as Trump said this week, he is in no hurry to reach a deal.

I am pretty sure he means that China is not yet sufficiently subdued.

Steven W. Mosher is the author of “Bully of Asia: Why China’s Dream is the New Threat to World Order.”


https://nypost.com/2018/10/06/trump-has-china...its-boots/
big-wave_surfing_01.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Western Microsurgical Expands Through Strategic Acquisitions

Updated Category News Views 67

Western Microsurgical's Bold Moves Western Microsurgical (WMS) is out here making waves, pulling off some serious strategic plays with the acquisitions of Q Surgical and Proficient Surgical. Now, this ain't some fly-by-night decision—this is about securing territory and leveling up their game in surgical microscopes and operating room supplies. With a footprint that'll...

Continue Reading
U.S.-Saudi Business Leaders Eye Growth Amid Challenges

Updated Category News Views 107

Revitalizing a Strategic Partnership Monday's meeting of the U.S.-Saudi Business Council wasn't just another gathering of suits; it was about re-kindling the investment flame between these two economic giants. Chaired by powerhouses Lubna Olayan and Jane Fraser, this wasn't a mere photo op. It was a call to arms in a landscape riddled with hurdles but bursting with...

Continue Reading
DexCom Faces Scrutiny: Fiduciary Breach Questioned

Updated Category News Views 190

Is DexCom’s Leadership Under The Gun? Here's the scoop, folks—DexCom, Inc. (NASDAQ:DXCM) has been hit with some serious questions recently. Nothing like a potential fiduciary breach to shake things up. October 27, 2026, is when the news broke, with Halper Sadeh LLC taking the reins on this investigation. They’re poking around to see if DexCom’s top dogs stumbled...

Continue Reading
North Fork Mono Casino Opens: A $750 Million Bet

Updated Category News Views 57

A New Spin in Madera Cue the fanfare, folks! The North Fork Mono Casino just threw open its doors earlier than expected today, marking a hefty $750 million wager right in the heart of California's Central Valley. It's a big deal managed by Station Casinos, part of Red Rock Resorts, Inc. (NASDAQ: RRR)—teaming up with the North Fork Rancheria of Mono Indians for a...

Continue Reading
DICK'S Sporting Goods Faces Investor Lawsuit Deadline Looms

Updated Category News Views 23

A Rough Tumble for DICK'S Sporting Goods Let's cut to the chase: DICK'S Sporting Goods, Inc. (NYSE:DKS) just took a nosedive. We're talking a hard 30.68% fall on the stock, plummeting to $124.31 a share as of August 25, 2026. Now, if you were caught up in this whirlwind as an investor, you'd be forgiven for having a few choice words for the powers that be over at DICK'S....

Continue Reading
Noma Hits Fortune Cyber 60 with AI Security Success

Updated Category News Views 13

Celebrating an AI Security Standout Well, look at that, Noma's found itself on the Fortune Cyber 60 list for 2026-2027. This listing isn't just some vanity metric. We’re talking about getting the nod from heavyweights like Lightspeed Venture Partners and Amazon Web Services. It recognizes them among 60 pivotal, venture-backed cybersecurity players, and sure, it’s in...

Continue Reading
oToBrite Unveils Avant-Garde Robotics Vision Tech at ROBOTWORLD

Updated Category News Views 57

An Eye on the Future: oToBrite's Bold Vision for Robotics Strolling down the aisles at ROBOTWORLD 2026, there's a palpable energy buzzing around oToBrite's booth. These folks are showcasing vision technology that's not just about snapping slick photos—it's about reshaping how machines see the world. And, let me tell you, if there’s one place to flaunt cutting-edge...

Continue Reading
Bank Leumi Q3 Earnings Preview: Key Dates & Insights

Updated Category News Views 61

A Closer Look at Bank Leumi's Upcoming Q3 Release Take a seat, folks. Bank Leumi’s gearing up to spill the beans on their Third Quarter 2026 earnings come November 17th. If you’re in the financial world, you might want to mark your calendar because these reports tend to shake things up. You know how these go - numbers rolling out, market responses, and plenty of...

Continue Reading
Jiahui's Bold Leap into Global Cell Therapy Market

Updated Category News Views 66

Jiahui's International Cell Therapy Center: A New Era Jiahui International Hospital is shaking up the healthcare scene with its fresh International Cell Therapy Center, diving headfirst into the cutting-edge world of CAR-T treatments. It's not every day you see this kind of bold move, especially from a player aiming to extend their reach both in China and abroad. Let's...

Continue Reading
CELSET Unveils SOLTOX: Expanding in Global Markets

Updated Category News Views 19

New Contender in the Global Botulinum Toxin Arena Launching a fresh player onto the international stage, CELSET INC. from Seoul throws down with SOLTOX, their own botulinum toxin Type A brand. This ain't your run-of-the-mill roll-out; it's another notch for Korean biotech trying to snag a piece of global market action. A Look at SOLTOX's Technical Makeup We’re talking...

Continue Reading